Comparative Effects of Dynamic Stability Drills and Plyometric Training After Anterior Crutiate Ligament Reconstruction

May 5, 2026 updated by: Riphah International University

Comparative Effects of Dynamic Stability Drills and Plyometric Training on Terminal Extension Lag After Anterior Cruciate Ligament Reconstruction

Terminal Extension lag (TEL) is a condition that develops when active range of extension is smaller than passive range; frequently noticed in post-traumatic knees after injuries and Anterior Cruciate ligament reconstruction surgery. TEL is typically seen within 6 to 12 weeks after ACL reconstruction. Anterior cruciate ligament reconstruction surgery is a critical surgical intervention used to repair ACL tear; which is common among those who are engaged in physical demanding activities and Sportsmen. In the initial days following surgery terminal extension lag affects up to 10 to 35% of individuals. ACL is expectational because it's not just a static stabilizer of knee but also transfers proprioceptive information to the brain so to improve joint's dynamics. This study aims to compare effects of Dynamic Stability Drills (DSD) and Plyometric Training (PT) in reducing terminal knee extension lag in post-ACL reconstruction patients. This study will be a Randomized Clinical Trail and will be conducted in Physiotherapy Department of Bethania Hospital Sialkot. Non-Probability Convenience Sampling will be used to collect data. Total of 48 Participants of the age 20 to 40 years with terminal extension lag of moderate lag stage (typically 9-12 weeks post-op with 5-10° lag) will be selected as sample size. An informed consent will be taken prior study from all the subjects. Outcomes measure will be included Numerical Pain Rating Scale (NPRS) for pain, Single Leg Hope Test and Y Balance Test (Y-BAL) for Dynamic Stability, Universal Goniometer (UG) for Range of Motion, Sphygmomanometer for Knee Strength, International Knee Documentation Committee scores, (IKDC) for Knee function and Limb Symmetry Index (LSI) Calculations. Subjects will be divided into two groups by random number generator table. Both groups will receive a standard physiotherapy protocols which will include: Hot pack , TENS , Mobilizations, Stretching and Strengthening. Group A will receive Dynamic Stability Drills and Group B will receive Plyometric Training along with conventional treatment. Patient will come 3 time a week and data will be recollected after 6 weeks. Data will be analyzed by SPSS version 25.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
48

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 20-40
  • Both Genders (male & female)
  • History of Anterior Cruciate Ligament Reconstruction (ACLR) between 1-3 years
  • Moderate stage (5 to 10 ˚) of terminal extension lag after ACL reconstruction

Exclusion Criteria:

  • Any other previously serious knee pain and/or surgery limiting of knee range of motion(2)
  • Any traumatic conditions around the knee, or any infectious or tumors conditions i.e.

meniscus injury, fracture, dislocation or osteochondral injury

  • Pregnancy, any recently underwent abdominal and back surgery
  • BMI ≥ 30 kg/m²
  • Any systemic and/or neurological illness, rheumatoid arthritis, osteomyelitis, any neurological disorders, spinal disorders, obesity, Dementia, inflammatory conditions like Ankylosing spondylitis, Rheumatoid arthritis, Osteoporosis, Diabetic neuropathy,
  • Red flags such as Trauma, Cancer, Constitutional Symptoms (Fever, Malaise, Weight Loss), Recent Infection, Mental retardation, Hemiparesis / Hemiplegia
  • Subjects with presence of any fractures
  • Heart/diabetic patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Plyometric Training
Other: Plyometric Training

Weak 1-2:

Four types of plyometrics:

A) bilateral off-set (alternating box jump) B) bilateral asymmetrical (split jump) C) bilateral symmetrical (30 cm drop jump) and

D) unilateral (30 cm drop jump(13) Weak 3-4:

  1. A lateral jump from left to right limb (A) with landing (B) and immediate jump back to the right limb (C) as opposed to just landing in which occurs during Stage 2(13).
  2. Images of a countermovement or squat jump in place with maximal height. The removal of the box results in higher landing forces due to landing from a higher height(13
Experimental: Dynamic Stability Drills
Other: Dynamic Stability Drills
Weak 1-2 Stability Foundation Weight shifts (anterior/posterior, lateral, Double-leg stance on foam surface, Eyes-closed balance (double-leg), Isometric quad & hamstring contractions, Wall sits + small ball between knees (activate adductors & quads)Weeks 3-4: Progressive Dynamic Stability, Single-leg stance on foam, Thera-band perturbation drills (knees and hips), TKE (Terminal Knee Extension) on unstable surfaces, Step-downs from 6-inch height (with control),Lateral step-overs (slow & controlled)

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Single leg hope test
Time Frame: 6th week
Jumping as far as you can on one leg while maintaining your balance and landing firmly is the goal of this challenge. The starting line and the landing leg's heel are used to estimate the distance
6th week
Limb Symmetry Index (LSI) Calculation
Time Frame: 6th week
the Limb Symmetry Index (LSI) calculates the performance difference between two limbs, typically the affected and unaffected limbs following an accident; by dividing the score of the injured limb by the score of the unaffected limb and multiplying the result by 100. It's represented in percentage
6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Rabiya Noor, PhD, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 15, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 15, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 15, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 5, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 5, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 11, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 11, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 5, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/RCR&AHS/25/0148

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings